{"id":"NCT00296335","sponsor":"Asan Medical Center","briefTitle":"Trial of Adjuvant Chemotherapy for Gastric Cancer","officialTitle":"A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Advanced Gastric Adenocarcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-02","primaryCompletion":"2007-11","completion":"2009-12","firstPosted":"2006-02-27","resultsPosted":"2014-02-27","lastUpdate":"2014-02-27"},"enrollment":855,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Stomach Cancer"],"interventions":[{"type":"DRUG","name":"Mitomycin, doxifluridine and cisplatin","otherNames":[]},{"type":"DRUG","name":"Mitomycin and doxifluridine","otherNames":[]}],"arms":[{"label":"Mitomycin and doxifluridine","type":"ACTIVE_COMPARATOR"},{"label":"Mitomycin, doxifluridine and cisplatin","type":"EXPERIMENTAL"}],"summary":"This is a phase III randomized study designed to evaluate the efficacy of mitomycin, doxifluridine, and cisplatin compared to mitomycin and doxifluridine.","primaryOutcome":{"measure":"Relapse-free Survival Rate","timeFrame":"3 years","effectByArm":[{"arm":"Mitomycin Plus Short-term Fluoropyrimidine","deltaMin":67,"sd":null},{"arm":"Mitomycin Plus Long-term Fluoropyrimidine and Monthly Cisplati","deltaMin":64.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":7},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":422},"commonTop":["Anemia","Fatigue","Anorexia","Nausea","Neutropenia"]}}